EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”

Tempei Otsubo iD, Koichiro Watanabe iD, Takeshi Inoue, Ataru Inagaki, Toshiaki Kikuchi, Keisuke Nomoto iD, Shingo Higa, Yuko Asami, Bin Sun, Kristina Marschall

Psychiatry and Clinical Neurosciences · 2026

DOI: 10.1111/pcn.70027 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Psychiatry and Clinical Neurosciences, 2026. Verfasst von Tempei Otsubo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic and Psychiatric Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Venlafaxine Hydrochloride, Generalized Anxiety Disorder, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Viatris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article relates to clinical relevance of venlafaxine ER for generalized anxiety disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venlafaxine HydrochlorideGeneralized Anxiety DisorderSerotonin and Noradrenaline Reuptake InhibitorsHumansDelayed-Action Preparations

Substanzen

Venlafaxine HydrochlorideSerotonin and Noradrenaline Reuptake InhibitorsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Psychosomatic and Psychiatric Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
  • Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
  • Department of Psychiatry, Sapporo Hanazono Hospital, Sapporo, Japan.
  • Department of Psychiatry, Tokyo Medical University, Tokyo, Japan.
  • Aoyama Gakuin University, Department of Education, College of Education, Psychology and Human Studies/Health Administration Center, Tokyo, Japan.
  • Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

ORCID-Profile: Tempei Otsubo, Koichiro Watanabe, Keisuke Nomoto

Förderung

  • Viatris

Zitieren

APA

Otsubo, T., Watanabe, K., Inoue, T., Inagaki, A., Kikuchi, T., Nomoto, K., Higa, S., Asami, Y., Sun, B., & Marschall, K. (2026). Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.70027

Vancouver

Otsubo T, Watanabe K, Inoue T, Inagaki A, Kikuchi T, Nomoto K, et al. Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”. Psychiatry and Clinical Neurosciences. 2026. doi:10.1111/pcn.70027

BibTeX
@article{Otsubo2026,
  author = {Otsubo, Tempei and Watanabe, Koichiro and Inoue, Takeshi and Inagaki, Ataru and Kikuchi, Toshiaki and Nomoto, Keisuke and Higa, Shingo and Asami, Yuko and Sun, Bin and Marschall, Kristina},
  title = {Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2026},
  doi = {10.1111/pcn.70027}
}
Kostenlos starten →